With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday, May 05, 2026 at the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Prism Medico and Pharmacy Limited approved the allotment of 75 lakh equity shares at ₹10 per share (face value ₹10) and 50 lakh convertible warrants at ₹10 per warrant on a preferential basis. This preferential issue was authorised by a special resolution passed at an Extra-Ordinary General Meeting held on March 20, 2026, and received in-principle approval from BSE on March 25, 2026. The total capital raise through equity shares alone amounts to ₹7.5 crore. The meeting was held on May 5, 2026, and the details of allottees were enclosed separately with the exchange. The purpose of the fund raise is not specified in this filing.
This preferential allotment will dilute existing shareholders as new equity and warrants are being issued. The warrants, once converted, will further increase the equity base. The issue price at face value suggests no immediate dilution discount for new investors.